Call Options Transactions Made in Q2 2025 in Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX) during Q2 2025. The information is specifically focused on institutions that hold call options of MoonLake Immunotherapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
157K+ 113.35% |
$5.16M - $8.02M
|
296K
$16.4M
|
|
|
Aug 14, 2025
Q2 2025
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
CALL |
125KNew |
$4.11M - $6.38M
|
125K
$6.92M
|
|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
64.2K+ 96.11% |
$2.11M - $3.28M
|
131K
$7.25M
|
|
|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
17.5K+ 192.31% |
$575K - $893K
|
26.6K
$1.47M
|
|
|
Aug 14, 2025
Q2 2025
|
Barclays PLC
London, X0 |
BUY
|
CALL |
10KNew |
$328K - $511K
|
10K
$554K
|
|
|
Aug 14, 2025
Q2 2025
|
J. Goldman & CO LP
New York, NY |
SELL
|
CALL |
-10K- 50.0% |
$328K - $511K
|
10K
$554K
|
|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
SELL
|
CALL |
-15.7K- 17.29% |
$516K - $801K
|
75.1K
$4.16M
|